Movement Alert｜Eli Lilly Rises 3.94% in Regular Trading, Multiple Wall Street Firms Raise Price Targets After Blowout Q2 Earnings

Market Focus08-06

On August 6, Eli Lilly rose 3.94% in regular trading, trading at $1199.545/share with turnover of $644 million, extending gains following its blockbuster Q2 earnings report.

On the news front, multiple Wall Street firms raised their price targets on August 6: Jefferies to $1440 from $1350, Morgan Stanley to $1419 from $1347, BMO to $1400 from $1300, and Wells Fargo to $1330 from $1280, all maintaining overweight or equivalent ratings. The consensus mean target now stands at $1,324.62.

The upgrades follow Eli Lilly's Q2 results released on August 5, which massively exceeded expectations. Revenue reached $22.97 billion, up 48% year-over-year and beating the $20.69 billion estimate. Adjusted EPS came in at $8.38, surpassing the $6.01 consensus by 39%. Mounjaro generated $9.9 billion in revenue, up 91% and beating the $8.83 billion estimate. The company raised full-year revenue guidance to $85-$87 billion from $82-$85 billion. Additionally, CVS Health announced a collaboration with Eli Lilly to expand GLP-1 medication access through transparent pricing and same-day pharmacy pickup.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

1

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1174993916?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-06 21:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1174993916","market":"us","top_or_hot":-1,"title":"Movement Alert｜Eli Lilly Rises 3.94% in Regular Trading, Multiple Wall Street Firms Raise Price Targets After Blowout Q2 Earnings","media":"Market Focus","content":"<p><p>On August 6, Eli Lilly rose 3.94% in regular trading, trading at $1199.545/share with turnover of $644 million, extending gains following its blockbuster Q2 earnings report.</p><p>On the news front, multiple Wall Street firms raised their price targets on August 6: Jefferies to $1440 from $1350, Morgan Stanley to $1419 from $1347, BMO to $1400 from $1300, and Wells Fargo to $1330 from $1280, all maintaining overweight or equivalent ratings. The consensus mean target now stands at $1,324.62.</p><p>The upgrades follow Eli Lilly's Q2 results released on August 5, which massively exceeded expectations. Revenue reached $22.97 billion, up 48% year-over-year and beating the $20.69 billion estimate. Adjusted EPS came in at $8.38, surpassing the $6.01 consensus by 39%. Mounjaro generated $9.9 billion in revenue, up 91% and beating the $8.83 billion estimate. The company raised full-year revenue guidance to $85-$87 billion from $82-$85 billion. Additionally, CVS Health announced a collaboration with Eli Lilly to expand GLP-1 medication access through transparent pricing and same-day pharmacy pickup.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Eli Lilly Rises 3.94% in Regular Trading, Multiple Wall Street Firms Raise Price Targets After Blowout Q2 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Eli Lilly Rises 3.94% in Regular Trading, Multiple Wall Street Firms Raise Price Targets After Blowout Q2 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-06 21:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 6, Eli Lilly rose 3.94% in regular trading, trading at $1199.545/share with turnover of $644 million, extending gains following its blockbuster Q2 earnings report.</p><p>On the news front, multiple Wall Street firms raised their price targets on August 6: Jefferies to $1440 from $1350, Morgan Stanley to $1419 from $1347, BMO to $1400 from $1300, and Wells Fargo to $1330 from $1280, all maintaining overweight or equivalent ratings. The consensus mean target now stands at $1,324.62.</p><p>The upgrades follow Eli Lilly's Q2 results released on August 5, which massively exceeded expectations. Revenue reached $22.97 billion, up 48% year-over-year and beating the $20.69 billion estimate. Adjusted EPS came in at $8.38, surpassing the $6.01 consensus by 39%. Mounjaro generated $9.9 billion in revenue, up 91% and beating the $8.83 billion estimate. The company raised full-year revenue guidance to $85-$87 billion from $82-$85 billion. Additionally, CVS Health announced a collaboration with Eli Lilly to expand GLP-1 medication access through transparent pricing and same-day pharmacy pickup.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LLY","symbol_name":"礼来","start_time":0,"source_url":"","article_id":"1174993916","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1174993916","pubTimestamp":1786024191,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 6, Eli Lilly rose 3.94% in regular trading, trading at $1199.545/share with turnover of $644 million, extending gains following its blockbuster Q2 earnings report.On the news front,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LLY":"礼来"},"translate_title":"走势警报|礼来公司常规交易中上涨 3.94%，多家华尔街公司在第二季度盈利井喷后上调目标价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LLY":1},"content_text":"On August 6, Eli Lilly rose 3.94% in regular trading, trading at $1199.545/share with turnover of $644 million, extending gains following its blockbuster Q2 earnings report.On the news front, multiple Wall Street firms raised their price targets on August 6: Jefferies to $1440 from $1350, Morgan Stanley to $1419 from $1347, BMO to $1400 from $1300, and Wells Fargo to $1330 from $1280, all maintaining overweight or equivalent ratings. The consensus mean target now stands at $1,324.62.The upgrades follow Eli Lilly's Q2 results released on August 5, which massively exceeded expectations. Revenue reached $22.97 billion, up 48% year-over-year and beating the $20.69 billion estimate. Adjusted EPS came in at $8.38, surpassing the $6.01 consensus by 39%. Mounjaro generated $9.9 billion in revenue, up 91% and beating the $8.83 billion estimate. The company raised full-year revenue guidance to $85-$87 billion from $82-$85 billion. Additionally, CVS Health announced a collaboration with Eli Lilly to expand GLP-1 medication access through transparent pricing and same-day pharmacy pickup.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1174993916","isCrawlerRequest":true}